Pregabalin

This page is an automatically generated summary of information from the Federal Court, Federal Court of Appeal, Health Canada and other websites. This information should NOT be relied upon as it is automatically generated and has not been confirmed for accuracy.

Automatically generated on July 6, 2024.

Return to the list of Patented Medicine Litigation page.

LYRICA – Pfizer Canada Inc. (NOC Search)

Patents:

2134674: MYLAN, PHARMASCIENCE, TEVA, RATIOPHARM, APOTEX, NOVOPHARM
2255652: PHARMASCIENCE, APOTEX, NOVOPHARM, RATIOPHARM, TEVA, COBALT, MYLAN, RANBAXY, RIVA
2297163: MYLAN, TEVA, PHARMASCIENCE, RATIOPHARM, NOVOPHARM, APOTEX
2325045: TEVA, COBALT, MYLAN, RANBAXY, RIVA, PHARMASCIENCE, APOTEX, NOVOPHARM, RATIOPHARM
2327285: MYLAN, COBALT, PHARMASCIENCE, RIVA, RATIOPHARM, RANBAXY, NOVOPHARM, APOTEX

APOTEX

PM(NOC) – T-275-13

COBALT

PM(NOC) – T-415-12

MYLAN

PM(NOC) – T-331-11

NOVOPHARM

PM(NOC) – A-252-10 (2010 FCA 258) – T-1868-09 (2010 FC 409, 2010 FC 668)

PHARMASCIENCE

Appeal – A-405-19 (2020 FCA 55)
Section 8 – T-1434-14 (2015 FC 1134, 2019 FC 1272, 2019 FC 1271, 2020 FC 1176, 2020 FC 1175)
PM(NOC) – T-185-13 – T-556-11 (2013 FC 120)

RANBAXY

PM(NOC) – T-1498-11

RATIOPHARM

PM(NOC) – T-1422-09 (2011 FC 74)

RIVA

PM(NOC) – T-217-12 – T-275-12

TEVA

Appeal – A-140-17
Section 8 – T-1496-13 (2017 FC 332)

Return to the Patented Medicine Litigation page.

Pregabalin

Canadian Intellectual Property